Windtree Therapeutics Inc

WINT

Exchange: OTC
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000946486

SEC filings (opens in a new tab)

No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Windtree Therapeutics Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of WINT: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	12	12	0
Shares	208.2K	269.9K	+61.7K (+29.7%)
Value	$197.7K	$194.1K	−$3.60K (−1.8%)

New holders (2)

Institutions that held Windtree Therapeutics Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to WINT in Q4 2023
Institution	Shares	Value	% of portfolio
Virtu Financial LLC	38,877	$28.0K	0.00%
Citadel Advisors LLC	38,128	$27.4K	0.00%

Sold out (2)

Institutions that held Windtree Therapeutics Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of WINT in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Tower Research Capital LLC (TRC)	9,668	$9.18K
Federation des caisses Desjardins du Quebec	200	$190